The phospholipid composition of artificial lipid droplets enhances their deliverability and facilitates a broad Biodistribution in vivo and in vitro
Source abstract
Abstract
Artificial lipid droplets (aLDs) provide a useful tool to explore the multiple functionalities of intracellular lipid droplets (LDs). In this study we explored the dynamics and potential multidisciplinary applications of these lipid particles. We have optimised construction of fluorescently labelled aLDs to allow their tracking in various in vitro and in vivo models. Modifying the phospholipid membrane of aLDs achieved enhanced delivery efficiency to a broad range of cells with various origins leading to a wide biodistribution of aLDs to organ systems in both mice and zebrafish models. The broad targeting and stability of this new generation of aLDs holds promise to now utilise aLDs as a novel delivery system as well as offering a toolset for further investigation on intracellular LD dynamics and function. STATEMENT OF SIGNIFICANCE: Artificial lipid droplets (aLDs) are a novel nanoparticle tool for biomedical research, consisting of a phospholipid monolayer with a neutral core interior. They offer new opportunities for the delivery of lipids and proteins in vivo; however, the ability of aLD lipid composition to drive enhanced cellular delivery remains unexplored. Here, we demonstrate that enhancing aLD phospholipid complexity significantly increases in vitro cellular delivery across multiple cell types and offers broad organ biodistribution, including delivery to the brain, in both mice and zebrafish. These findings highlight aLDs as potential vehicles in both basic biological studies and therapeutic interventions. Additionally, increasing the complexity of phospholipids into alternate nanoparticles such as LNPs may enhance organ biodistribution, thus opening the field up to new opportunities for cargo to reach previously undeliverable areas.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Lipid metabolism and biosynthesis · Enzyme Catalysis and Immobilization · Adipose Tissue and Metabolism
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Dynamics and functions of lipid droplets10.1038/s41580-018-0085-z ↗
2. Lipid droplets as signaling platforms linking metabolic and cellular functions10.4137/LPI.S11128 ↗
3. Viperin interacts with the kinase IRAK1 and the E3 ubiquitin ligase TRAF6, coupling innate immune signaling to antiviral ribonucleotide synthesis10.1074/jbc.RA119.007719 ↗
4. Viperin binds STING and enhances the type-I interferon response following dsDNA detection10.1111/imcb.12420 ↗
5. Lipid droplet biogenesis and functions in health and disease10.1038/s41574-023-00845-0 ↗
6. Construction of nanodroplet/adiposome and artificial lipid droplets10.1021/acsnano.5b06852 ↗
7. Validating an artificial organelle: studies of lipid droplet-specific proteins on adiposome platform10.1016/j.isci.2021.102834 ↗
8. Construction and application of artificial lipoproteins using adiposomes10.1016/j.jlr.2023.100436 ↗
9. Artificial lipid droplets: novel effective biomaterials to protect cells against oxidative stress and lipotoxicity10.3390/nano12040672 ↗
10. Nanotechnology-Assisted cell tracking10.3390/nano12091414 ↗
11. Microneedle-mediated transdermal delivery of drug-carrying nanoparticles10.3389/fbioe.2022.840395 ↗
12. E.A. Monson, J.L. Laws, Z. Telikani, A.J. Milligan, A.M. Rozario, I. Amarasinghe, M.L. Smith, V. Tran, Q. Dinh, N. Williamson, A. Mechler, C. Johnson, M.J. Hofer, S. Nie, D.R. Whelan, K.J. Helbig, Virally induced lipid droplets are a platform for innate immune signalling complexes, (2023) 2023.04.20.537741. doi:10.1101/2023.04.20.537741.10.1101/2023.04.20.537741 ↗
13. Protocol for using artificial lipid droplets to study the binding affinity of lipid droplet-associated proteins10.1016/j.xpro.2022.101214 ↗
14. Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting10.1038/ng.321 ↗
15. Visualization and tools for analysis of zebrafish lymphatic development10.1007/978-1-4939-8712-2_4 ↗
16. Development of the zebrafish lymphatic system requires VEGFC signaling10.1016/j.cub.2006.05.026 ↗
17. Plexin D1 negatively regulates zebrafish lymphatic development10.1242/dev.200560 ↗
18. Intracellular lipid droplet accumulation occurs early following viral infection and is required for an efficient interferon response10.1038/s41467-021-24632-5 ↗
19. Cellular uptake of nanoparticles versus small molecules: a matter of size10.1021/acs.accounts.8b00292 ↗
20. G. Zhang, Z. Zhi, B. Pan, Z. Li, S. Zhang, Z. Wu, P. Bu, Z. Cao, P. Liu, Cationic adiposomes as a delivery system for Neogambogic acid for the treatment of multiple cancers, Advanced Therapeutics n/a (n.d.) 2400201. doi:10.1002/adtp.202400201.10.1002/adtp.202400201 ↗
21. The lipid droplet lipidome
22. Bacterial lipid droplets bind to DNA via an intermediary protein that enhances survival under stress
23. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting10.3402/jev.v4.26316 ↗
24. Anionic lipid nanoparticles preferentially deliver mRNA to the hepatic reticuloendothelial system10.1002/adma.202201095 ↗
25. Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism
26. Biodistribution of small interfering RNA at the organ and cellular levels after lipid nanoparticle-mediated delivery10.1369/0022155411410885 ↗
27. Effects of size and targeting ligand on biodistribution of liposome nanoparticles in tumor mice
28. A review on phospholipids and their main applications in drug delivery systems
29. Tailoring the lipid composition of nanoparticles modulates their cellular uptake and affects the viability of triple negative breast cancer cells10.1016/j.jconrel.2019.06.025 ↗
30. Receptor-targeted nanocarriers for therapeutic delivery to cancer10.3109/09687688.2010.521200 ↗
31. Receptor-mediated endocytosis10.1042/bj2320001 ↗
32. Liposome-cell interactions: in vitro discrimination of uptake mechanism and in vivo targeting strategies to mononuclear phagocytes10.1016/0009-3084(86)90080-0 ↗
33. Liposomes and extracellular vesicles as drug delivery systems: a comparison of composition
34. Biodistribution of extracellular vesicles following administration into animals: a systematic review10.1002/jev2.12085 ↗
35. Studying the fate of tumor extracellular vesicles at high spatiotemporal resolution using the zebrafish embryo10.1016/j.devcel.2019.01.014 ↗
36. Live tracking of inter-organ communication by endogenous exosomes In Vivo10.1016/j.devcel.2019.01.004 ↗
37. Zebrafish as an early stage screening tool to study the systemic circulation of nanoparticulate drug delivery systems in vivo10.1016/j.jconrel.2017.08.023 ↗
38. A comparative biodistribution study of polymeric and lipid-based nanoparticles10.1007/s13346-022-01157-y ↗
39. Lipid nanoparticles for hepatic delivery of small interfering RNA10.1016/j.biomaterials.2012.05.002 ↗
40. Biodistribution and non-linear gene expression of mRNA LNPs affected by delivery route and particle size10.1007/s11095-022-03166-5 ↗
41. Peptide-functionalized lipid nanoparticles for targeted systemic mRNA delivery to the brain10.1021/acs.nanolett.4c05186 ↗
42. L. Hong, W. Li, Y. Li, S. Yin, Nanoparticle-based drug delivery systems targeting cancer cell surfaces, RSC. Adv. 13 (n.d.) 21365–21382. doi:10.1039/d3ra02969g.10.1039/D3RA02969G ↗
43. Nanoparticle-based targeted drug delivery10.1016/j.yexmp.2008.12.004 ↗
44. Overview of physicochemical properties of nanoparticles as drug carriers for targeted cancer therapy10.3390/jfb13040196 ↗
45. Targeting strategies for tissue-specific drug delivery10.1016/j.cell.2020.02.001 ↗
46. Function of lipid droplet-organelle interactions in lipid homeostasis10.1016/j.bbamcr.2017.04.001 ↗
47. Biogenesis of the multifunctional lipid droplet: lipids, proteins, and sites10.1083/jcb.201311051 ↗